Crescent Biopharma, Inc.CBIONASDAQ
LOADING
|||
Switch Symbol:
Cash Generation Expanding
Trending higher, above historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-31.11M
↑ 17% above average
Average (9y)
$-37.40M
Historical baseline
Range
High:$-8.51M
Low:$-57.50M
CAGR
+15.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-31.11M | +10.9% |
| 2023 | $-34.90M | +25.0% |
| 2022 | $-46.54M | +19.1% |
| 2021 | $-57.50M | -46.3% |
| 2020 | $-39.31M | +24.6% |
| 2019 | $-52.13M | -20.0% |
| 2018 | $-43.46M | -44.6% |
| 2017 | $-30.06M | +1.2% |
| 2016 | $-30.44M | -257.6% |
| 2015 | $-8.51M | - |